Christopher Astle
Director of Finance/CFO bei Zymeworks BC, Inc.
Vermögen: 68 412 $ am 31.03.2024
Profil
Christopher Astle was the founder of Think Forwards, a company founded in 2017 where he held the title of Chief Executive Officer from 2017 to 2020.
He is currently working as a Director at Oak Bay Biosciences, Inc. since 2020, as a Director at Healome Therapeutics Ltd.
since 2021, and as the Chief Financial Officer & Senior Vice President at Zymeworks BC, Inc. since 2022.
Previously, he worked as the Vice President-Finance at Lundbeck Seattle BioPharmaceuticals, Inc. from 2019 to 2020, as the Associate VP-International Division Finance at Allergan (Canada) from 2016 to 2017, as the Chief Financial Officer at CFO Centre Ltd.
from 2020 to 2021, and as the Senior VP, Chief Financial & Accounting Officer at Zymeworks, Inc. from 2022 to 2024.
Dr. Astle obtained a graduate degree from The University of Liverpool and a doctorate degree from the University of Bristol.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ZYMEWORKS INC.
0,01% | 08.01.2024 | 6 503 ( 0,01% ) | 68 412 $ | 31.03.2024 |
Aktive Positionen von Christopher Astle
| Unternehmen | Position | Beginn |
|---|---|---|
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Director of Finance/CFO | 21.02.2022 |
| Oak Bay Biosciences, Inc. | Director/Board Member | 01.01.2020 |
| Healome Therapeutics Ltd. | Director/Board Member | 01.01.2021 |
Ehemalige bekannte Positionen von Christopher Astle
| Unternehmen | Position | Ende |
|---|---|---|
| ZYMEWORKS INC. | Director of Finance/CFO | 31.03.2024 |
CFO Centre Ltd.
 CFO Centre Ltd. Personnel ServicesCommercial Services CFO Centre Ltd. provides temporary staffing services. The private company is based in Toronto, Canada. | Director of Finance/CFO | 01.03.2021 |
| ALDER BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.02.2020 |
| Think Forwards | Chief Executive Officer | 01.01.2020 |
Allergan (Canada)
 Allergan (Canada) Pharmaceuticals: MajorHealth Technology Allergan operates as a pharmaceutical company. The company is headquartered in Unionville, Canada. | Corporate Officer/Principal | 01.07.2017 |
Ausbildung von Christopher Astle
| The University of Liverpool | Graduate Degree |
| University of Bristol | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ZYMEWORKS INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
Allergan (Canada)
Allergan (Canada) Pharmaceuticals: MajorHealth Technology Allergan operates as a pharmaceutical company. The company is headquartered in Unionville, Canada. | Health Technology |
CFO Centre Ltd.
CFO Centre Ltd. Personnel ServicesCommercial Services CFO Centre Ltd. provides temporary staffing services. The private company is based in Toronto, Canada. | Commercial Services |
| Think Forwards | |
| Oak Bay Biosciences, Inc. | |
| Healome Therapeutics Ltd. |
